Page last updated: 2024-10-30

letrozole and Non-alcoholic Fatty Liver Disease

letrozole has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"The prevalence of nonalcoholic fatty liver disease (NAFLD) is higher in women with polycystic ovarian syndrome (PCOS) than that in healthy women."1.56Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome. ( Chen, Y; Cui, T; Li, T; Liu, R; Yang, Y; Yin, C; Zhang, T, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hai, Y1
Zuo, L1
Wang, M2
Zhang, R1
Ren, L1
Yang, C1
Wang, J1
Li, T1
Zhang, T1
Cui, T1
Yang, Y1
Liu, R1
Chen, Y1
Yin, C1

Other Studies

2 other studies available for letrozole and Non-alcoholic Fatty Liver Disease

ArticleYear
Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation.
    Molecules (Basel, Switzerland), 2023, Jan-05, Volume: 28, Issue:2

    Topics: Animals; Diet, High-Fat; Fatty Acids; Female; Follicle Stimulating Hormone; Humans; Letrozole; Lipid

2023
Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome.
    The Journal of steroid biochemistry and molecular biology, 2020, Volume: 204

    Topics: Adult; AMP-Activated Protein Kinases; Androgens; Animals; Aromatase Inhibitors; Dihydrotestosterone;

2020